Securities Code: 300246
Bond Code: 123065
Securities Abbreviation: Baolight
Bond Abbreviation: Baolight Convertible Bond
Announcement Number: 2026-039
Guangdong Baolight Medical Technology Co., Ltd.
Announcement on Downward Adjustment of Convertible Bond Conversion Price
The Company and all members of its Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement, and that there are no false records, misleading statements, or material omissions.
Special Reminder:
-
Bond Code: 123065; Bond Abbreviation: Baolight Convertible Bond
-
Pre-adjustment Conversion Price: RMB 23.80/share
-
Post-adjustment Conversion Price: RMB 18.30/share
-
Effective Date of Post-adjustment Conversion Price: June 22, 2026
I. Overview of Convertible Bond Issuance and Listing
(I) Basic Situation of Convertible Bond Issuance and Listing
After review and approval by the GEM Listing Committee of the Shenzhen Stock Exchange in its 8th meeting in 2020, and with the approval of the China Securities Regulatory Commission (Document No. [2020]1831), the Company issued 2.19 million convertible corporate bonds to non-specific targets on September 4, 2020. Each bond has a face value of RMB 100, with a total issuance amount of RMB 219 million.
The Company's RMB 219 million convertible corporate bonds were listed and traded on the Shenzhen Stock Exchange on September 24, 2020, under the bond abbreviation "Baolight Convertible Bond" and bond code "123065".
Conversion Period for Convertible Corporate Bonds: March 11, 2021, to September 3, 2026 (if it falls on a statutory holiday or rest day, it will be extended to the first business day thereafter; interest payments during the extension period will not accrue interest).